155 related articles for article (PubMed ID: 8647853)
21. Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires.
Sidney J; Southwood S; Sette A
Immunogenetics; 2005 Jul; 57(6):393-408. PubMed ID: 16003466
[TBL] [Abstract][Full Text] [Related]
22. A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.
Hülsmeyer M; Chames P; Hillig RC; Stanfield RL; Held G; Coulie PG; Alings C; Wille G; Saenger W; Uchanska-Ziegler B; Hoogenboom HR; Ziegler A
J Biol Chem; 2005 Jan; 280(4):2972-80. PubMed ID: 15537658
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype.
Sidney J; Southwood S; Pasquetto V; Sette A
J Immunol; 2003 Dec; 171(11):5964-74. PubMed ID: 14634108
[TBL] [Abstract][Full Text] [Related]
24. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA
J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734
[TBL] [Abstract][Full Text] [Related]
25. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8.
DiBrino M; Parker KC; Shiloach J; Turner RV; Tsuchida T; Garfield M; Biddison WE; Coligan JE
J Immunol; 1994 Jan; 152(2):620-31. PubMed ID: 7506728
[TBL] [Abstract][Full Text] [Related]
26. New MAGE-4 antigenic peptide recognized by cytolytic T lymphocytes on HLA-A1 tumor cells.
Kobayashi T; Lonchay C; Colau D; Demotte N; Boon T; van der Bruggen P
Tissue Antigens; 2003 Nov; 62(5):426-32. PubMed ID: 14617050
[TBL] [Abstract][Full Text] [Related]
27. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.
van der Bruggen P; Bastin J; Gajewski T; Coulie PG; Boël P; De Smet C; Traversari C; Townsend A; Boon T
Eur J Immunol; 1994 Dec; 24(12):3038-43. PubMed ID: 7805731
[TBL] [Abstract][Full Text] [Related]
28. A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes.
Schultz ES; Zhang Y; Knowles R; Tine J; Traversari C; Boon T; van der Bruggen P
Tissue Antigens; 2001 Feb; 57(2):103-9. PubMed ID: 11260504
[TBL] [Abstract][Full Text] [Related]
29. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
Valmori D; Liénard D; Waanders G; Rimoldi D; Cerottini JC; Romero P
Cancer Res; 1997 Feb; 57(4):735-41. PubMed ID: 9044853
[TBL] [Abstract][Full Text] [Related]
30. Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentiviruses.
Breckpot K; Heirman C; De Greef C; van der Bruggen P; Thielemans K
J Immunol; 2004 Feb; 172(4):2232-7. PubMed ID: 14764691
[TBL] [Abstract][Full Text] [Related]
31. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
Traversari C; van der Bruggen P; Luescher IF; Lurquin C; Chomez P; Van Pel A; De Plaen E; Amar-Costesec A; Boon T
J Exp Med; 1992 Nov; 176(5):1453-7. PubMed ID: 1402688
[TBL] [Abstract][Full Text] [Related]
32. Interaction of antigenic peptides with MHC class I molecules on living cells studied by photoaffinity labeling.
Luescher IF; Lóez JA; Malissen B; Cerottini JC
J Immunol; 1992 Feb; 148(4):1003-11. PubMed ID: 1737923
[TBL] [Abstract][Full Text] [Related]
33. Perspectives for immunization of HLA-A1 patients carrying a malignant melanoma expressing gene MAGE-1.
Marchand M; Brasseur F; van der Bruggen P; Coulie P; Boon T
Dermatology; 1993; 186(4):278-80. PubMed ID: 8513199
[TBL] [Abstract][Full Text] [Related]
34. Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles.
Celis E; Fikes J; Wentworth P; Sidney J; Southwood S; Maewal A; Del Guercio MF; Sette A; Livingston B
Mol Immunol; 1994 Dec; 31(18):1423-30. PubMed ID: 7823968
[TBL] [Abstract][Full Text] [Related]
35. Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules.
Berke Z; Andersen MH; Pedersen M; Fugger L; Zeuthen J; Haurum JS
Leukemia; 2000 Mar; 14(3):419-26. PubMed ID: 10720136
[TBL] [Abstract][Full Text] [Related]
36. Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes.
Tahara K; Takesako K; Sette A; Celis E; Kitano S; Akiyoshi T
Clin Cancer Res; 1999 Aug; 5(8):2236-41. PubMed ID: 10473111
[TBL] [Abstract][Full Text] [Related]
37. Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity.
Kumar P; Vahedi-Faridi A; Saenger W; Ziegler A; Uchanska-Ziegler B
Protein Sci; 2009 Jan; 18(1):37-49. PubMed ID: 19177349
[TBL] [Abstract][Full Text] [Related]
38. Photoaffinity labeling of the T cell receptor on cloned cytotoxic T lymphocytes by covalent photoreactive ligand.
Luescher IF; Cerottini JC; Romero P
J Biol Chem; 1994 Feb; 269(8):5574-82. PubMed ID: 8119892
[TBL] [Abstract][Full Text] [Related]
39. Identification of a new MAGE-A10 antigenic peptide presented by HLA-A*0201 on tumor cells.
Jia ZC; Tian Y; Huang ZM; Wang JX; Fu XL; Ni B; Wu YZ
Cancer Biol Ther; 2011 Feb; 11(4):395-400. PubMed ID: 21124073
[TBL] [Abstract][Full Text] [Related]
40. Analysis of HLA-B*44 alleles encoded on extended HLA haplotypes by direct automated sequencing.
Petersdorf EW; Setoda T; Smith AG; Hansen JA
Tissue Antigens; 1994 Oct; 44(4):211-6. PubMed ID: 7871521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
